Wehr, M. C., Hinrichs, W., Brzózka, M. M., Unterbarnscheidt, T., Herholt, A., Wintgens, J. P., . . . Rossner, M. J. (2017). Spironolactone is an antagonist of NRG1‐ERBB4 signaling and schizophrenia‐relevant endophenotypes in mice. EMBO Mol Med.
Styl ChicagoWehr, Michael C., et al. "Spironolactone Is an Antagonist of NRG1‐ERBB4 Signaling and Schizophrenia‐relevant Endophenotypes in Mice." EMBO Mol Med 2017.
Citace podle MLAWehr, Michael C., et al. "Spironolactone Is an Antagonist of NRG1‐ERBB4 Signaling and Schizophrenia‐relevant Endophenotypes in Mice." EMBO Mol Med 2017.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..